Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


HRT vs. supplements

This article was originally published in The Tan Sheet

Executive Summary

Dietary Supplement Education Alliance is spending "in the five figures" to develop video news release (VNR) promoting supplement ingredients as alternatives to hormone replacement therapy for menopausal symptoms. Slated for release in early to mid August, the VNR will be accessible by every TV station in U.S. for possible inclusion in local news health segments. Two- to three-minute feature will include interviews with two Los Angeles-based doctors. Supplement marketers also are stepping up PR efforts following studies raising concerns about safety of long-term HRT use. GlaxoSmithKline (Remifemin) reps are now calling on family practitioners as well as OB/GYNs. Novogen is alerting independent pharmacists about safety, efficacy of its Promensil supplement, while Rexall (Sundown Menopause Support) is planning additional in-store promotions that may reference articles on HRT studies...

Related Content

Menopause remedy sales
Pharmaton Repackages Supplement Line; Launches Women’s Health Product





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts